Plus Therapeutics to Present In-Person at the H.C. Wainwright 24th Annual Global Investment Conference
08.09.2022 - AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) - Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that Marc ... Seite 1